Nexus Letter for Hypertension Secondary to PTSD: What to Include (2026)

Why Hypertension Secondary to PTSD Is a Strong Theory

Veterans with service-connected PTSD develop hypertension at higher rates than the general population. Cohort studies of post-9/11 veterans, Vietnam-era veterans, and active duty service members consistently show elevated incidence of hypertension and cardiovascular disease in PTSD populations, even after controlling for demographic and lifestyle factors. The mechanisms are biologically plausible and well-described, which means a thoughtful nexus letter has a strong foundation to build on.

Importantly, the VA does not require a presumption to grant secondary service connection. Under 38 CFR 3.310, the standard is that the secondary condition is "at least as likely as not" caused or aggravated by the primary service-connected condition. The medical literature supporting the PTSD-to-hypertension link is robust enough that a properly constructed opinion routinely meets that threshold.

Pathway 1: Chronic Sympathetic Activation

PTSD is fundamentally a disorder of the threat-detection system. The sympathetic nervous system - which prepares the body for fight, flight, or freeze - remains chronically activated even when no actual threat is present. The cardiovascular consequences include:

• Increased heart rate and stroke volume
• Peripheral vasoconstriction with elevated peripheral vascular resistance
• Activation of the renin-angiotensin-aldosterone system, which promotes sodium retention and further vasoconstriction
• Endothelial dysfunction over time, reducing the vasculature's ability to dilate

The cumulative result of chronic sympathetic over-drive is sustained elevation in blood pressure that progresses, in many veterans, to clinical hypertension. This pathway is described in standard cardiology and psychiatry texts and in numerous peer-reviewed studies of veterans with PTSD.

Pathway 2: HPA Axis Dysregulation

The hypothalamic-pituitary-adrenal (HPA) axis is the body's stress hormone system. PTSD produces complex HPA dysregulation - sometimes elevated cortisol, sometimes blunted cortisol responses, but consistently disrupted normal cortisol rhythms. Cortisol contributes to blood pressure regulation through:

• Sodium and water retention via mineralocorticoid receptor effects
• Up-regulation of adrenergic receptors, increasing the response to circulating catecholamines
• Promotion of insulin resistance and metabolic syndrome features

The literature on HPA dysregulation in PTSD veterans is substantial and provides credible biological grounding for the cardiovascular consequences.

Pathway 3: Sleep Disturbance and Sleep Apnea

PTSD profoundly disrupts sleep architecture. Veterans with PTSD experience reduced REM sleep, fragmented non-REM sleep, frequent nighttime awakenings, and elevated arousal thresholds. Two related cardiovascular consequences follow:

• Direct effects of sleep deprivation on blood pressure regulation, which include impaired baroreceptor sensitivity and elevated overnight blood pressure
• Increased prevalence of obstructive sleep apnea in veterans with PTSD, which independently raises blood pressure through hypoxia-induced sympathetic activation and intrathoracic pressure changes

For veterans who already have service-connected sleep apnea or are pursuing sleep apnea claims, the sleep pathway provides an additional route to support the hypertension claim.

Pathway 4: Psychotropic Medication Effects

The medications used to treat PTSD have measurable cardiovascular and metabolic effects. Many SSRIs and SNRIs produce weight gain, which is a major modifiable hypertension risk factor. Some agents have direct vasoactive effects. The interplay is documented in the prescribing information and in the cardiovascular pharmacology literature:

• SSRIs (sertraline, paroxetine, fluoxetine) and SNRIs (venlafaxine, duloxetine) often produce weight gain that contributes to insulin resistance and hypertension
• Some SNRIs (notably venlafaxine at higher doses) can directly elevate blood pressure
• Mirtazapine, which is sometimes used adjunctively for sleep, is associated with significant weight gain
• Long-term sedative-hypnotic use can be associated with weight gain through changed activity patterns

Pathway 5: Chronic Inflammation

Chronic stress and PTSD are associated with elevated inflammatory markers - C-reactive protein, interleukin-6, tumor necrosis factor alpha. Vascular inflammation contributes to endothelial dysfunction and atherosclerosis, both of which raise blood pressure over time. While the inflammation pathway alone is rarely the centerpiece of a nexus letter, it adds depth when included alongside the autonomic, HPA, and sleep pathways.

How the VA Rates Hypertension

Hypertension is rated under 38 CFR 4.104, Diagnostic Code 7101. The criteria are:

• 10 percent - Diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more, or with continuous medication required for control where there is a history of diastolic readings predominantly 100 or more
• 20 percent - Diastolic pressure predominantly 110 or more, or systolic pressure predominantly 200 or more
• 40 percent - Diastolic pressure predominantly 120 or more
• 60 percent - Diastolic pressure predominantly 130 or more

For VA rating purposes, hypertension means diastolic blood pressure predominantly 90 or more, or systolic blood pressure predominantly 160 or more, with hypertension confirmed by two or more readings on at least three different days. Most veterans on stable antihypertensive treatment receive a 10 percent rating, since medication keeps diastolic readings below the higher tier thresholds. The 10 percent rating is meaningful both for compensation and for protecting against future cardiovascular complications that may also be claimed as secondary.

What the Nexus Letter Must Include

A defensible secondary nexus letter for hypertension secondary to PTSD typically addresses:

1. Identification of service-connected PTSD with effective date and current rating if known
2. Identification of current hypertension diagnosis with the relevant diagnostic criteria met
3. Scope of records reviewed - service treatment records, mental health notes, primary care and cardiology records, blood pressure trend over time, medication history
4. Summary of PTSD severity and treatment course
5. Articulation of the relevant pathway(s) - chronic sympathetic activation, HPA dysregulation, sleep disturbance, medication effects, or a combination
6. Reference to the medical literature supporting the pathway
7. The "at least as likely as not" opinion with proper VA phrasing
8. An aggravation analysis in the alternative with baseline per Allen v. Brown, where applicable
9. Physician credentials and signature

Supporting Evidence

Beyond the nexus letter itself, the VA looks at:

• Service-connected PTSD documentation with effective date
• Mental health records showing PTSD severity, treatment, and medication history
• Primary care and cardiology records showing the hypertension diagnosis, medication regimen, and blood pressure trends
• Documentation of when hypertension first appeared in the medical record relative to PTSD onset and treatment
• Where applicable, sleep study results and documentation of service-connected sleep apnea
• Medication history with weight changes and metabolic data
• Lay statements describing the relationship between stress events and blood pressure exacerbations, where credible

Mistakes to Avoid

• Conclusory opinions that say PTSD causes hypertension without articulating the pathway
• Generic stress language rather than specific physiological mechanisms
• Ignoring the medication pathway when the veteran is on SSRIs or SNRIs
• Failing to address pre-existing hypertension as an aggravation theory under Allen v. Brown
• Skipping the records review in favor of a brief opinion based on patient self-report alone
• Outdated literature citations when current peer-reviewed sources are available
• Wrong standard of proof - "may be related" rather than "at least as likely as not"